FDA spotlights innovation in 3-D imaging

Breast cancer detection may soon leave 2-D mammography in the dust, embracing instead a more comprehensive diagnostic tool: 3-D technology. By embracing the future of 3-D breast tomosynthesis, doctors can pinpoint the size and location of cancer tumors in dense breast tissue with more accuracy. This is done by creating an artificial 3-D image of the breast from a limited set of 2-D images, revealing sections of the breast that can be hidden by overlapping tissue in standard 2-D mammograms. Story

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.